Pathology of primary malignant bone and cartilage tumours

被引:84
作者
Rozeman, L. B. [1 ]
Cleton-Jansen, A. M. [1 ]
Hogendoorn, P. C. W. [1 ]
机构
[1] Leiden Univ, Med Ctr, Dept Pathol, NL-2300 RC Leiden, Netherlands
关键词
D O I
10.1007/s00264-006-0212-x
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Bone- and cartilage-forming tumours ( osteosarcomas and chondrosarcomas) are rare malignant neoplasms. These tumours are clinically aggressive and often need extensive local and/or systemic treatment. Whereas no other treatment but surgery is currently available for chondrosarcomas, osteosarcomas show an approximately 50-80% response rate to adjuvant chemotherapy. Surgical removal of these tumours is currently mostly performed with limb salvage, but amputation may be required in some cases. In addition, the tumours have a risk of local recurrences adversely affecting the prognosis compared to the primary tumour. In this report we will mainly focus on two of the most prevalent malignant bone tumours, conventional osteosarcoma and conventional chondrosarcoma, and use these to illustrate the problems with the diagnosis of bone sarcomas in general.
引用
收藏
页码:437 / 444
页数:8
相关论文
共 36 条
  • [1] Overexpression of the HER-2 oncogene does not play a role in high-grade osteosarcomas
    Anninga, JK
    van de Vijver, MJ
    Cleton-Jansen, AM
    Kristel, PMP
    Taminiau, AHM
    Nooij, M
    Egeler, RM
    Hogendoorn, PCW
    [J]. EUROPEAN JOURNAL OF CANCER, 2004, 40 (07) : 963 - 970
  • [2] Bertoni F., 2002, WHO CLASSIFICATION T, P247
  • [3] Prognostic factors in high-grade osteosarcoma of the extremities or trunk:: An analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols
    Bielack, SS
    Kempf-Bielack, B
    Delling, G
    Exner, GU
    Flege, S
    Helmke, K
    Kotz, R
    Salzer-Kuntschik, M
    Werner, M
    Winkelmann, W
    Zoubek, A
    Jürgens, H
    Winkler, K
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (03) : 776 - 790
  • [4] Near-haploidy and subsequent polyploidization characterize the progression of peripheral chondrosarcoma
    Bovée, JVMG
    van Royen, M
    Bardoel, AFJ
    Rosenberg, C
    Cornelisse, CJ
    Cleton-Jansen, AM
    Hogendoorn, PCW
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2000, 157 (05) : 1587 - 1595
  • [5] Bovée JVMG, 1999, J PATHOL, V189, P454, DOI 10.1002/(SICI)1096-9896(199912)189:4<454::AID-PATH467>3.0.CO
  • [6] 2-N
  • [7] Emerging pathways in the development of chondrosarcoma of bone and implications for targeted treatment
    Bovée, JVMG
    Cleton-Jansen, AM
    Taminiau, AHM
    Hogendoorn, PCW
    [J]. LANCET ONCOLOGY, 2005, 6 (08) : 599 - 607
  • [8] Burak Z, 2003, J NUCL MED, V44, P1394
  • [9] Methylthioadenosine phosphorylase gene deletions are frequently detected by fluorescence in situ hybridization in conventional chondrosarcomas
    Chow, WA
    Victoria, B
    Gaytan, P
    Borden, E
    Goldblum, J
    Hicks, D
    Slovak, ML
    [J]. CANCER GENETICS AND CYTOGENETICS, 2006, 166 (02) : 95 - 100
  • [10] Estrogen signaling is active in cartilaginous tumors:: Implications for antiestrogen therapy as treatment option of metastasized or irresectable chondrosarcoma
    Cleton-Jansen, AM
    van Beerendonk, HM
    Baelde, HJ
    Bovée, JVGM
    Karperien, M
    Hogendoorn, PCW
    [J]. CLINICAL CANCER RESEARCH, 2005, 11 (22) : 8028 - 8035